Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)45-47
    Number of pages3
    JournalBreast Diseases
    Volume25
    Issue number1
    DOIs
    StatePublished - Mar 17 2014

    ASJC Scopus subject areas

    • Surgery
    • Oncology

    Cite this